Literature DB >> 15992397

Personality measures in former heroin users receiving methadone or in protracted abstinence from opiates.

L J Cohen1, E Gertmenian-King, L Kunik, C Weaver, E D London, I Galynker.   

Abstract

OBJECTIVE: Methadone Maintenance Therapy (MMT) and detoxification to abstinence are among the most common treatment options for opiate-dependent patients. This paper compares personality traits in detoxified former heroin users and those on MMT in order to assess their relevance to treatment selection.
METHOD: Twenty-six formerly heroin-dependent subjects receiving MMT (MM), 33 formerly heroin-dependent subjects withdrawn from MMT (MW), and 43 healthy controls were compared on the Millon Clinical Multiaxial Inventory-II (MCMI-II) and the Temperament and Character Inventory (TCI).
RESULTS: On the TCI, MM patients had higher novelty seeking and lower self-directedness scores than controls. Both MM and MW subjects scored higher than controls on multiple MCMI-II scales. MW but not MM subjects scored higher than controls on two Cluster A Scales and the delusional disorder scale.
CONCLUSION: Schizophrenia-spectrum pathology in former opiate users may be greater than previously recognized and could potentially be relevant to treatment selection. Copyright Blackwell Munksgaard 2005.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15992397      PMCID: PMC2067989          DOI: 10.1111/j.1600-0447.2005.00546.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  40 in total

1.  Rapid heroin detoxification under general anesthesia.

Authors:  R J Laheij; P F Krabbe; C A de Jong
Journal:  JAMA       Date:  2000-03-01       Impact factor: 56.272

2.  Validation of MMPI profile subtypes among opioid addicts who are beginning methadone maintenance treatment.

Authors:  D A Calsyn; D K Roszell; E F Chaney
Journal:  J Clin Psychol       Date:  1989-11

3.  Changes in Millon Clinical Multiaxial Inventory scores among opiate addicts as a function of retention in methadone maintenance treatment and recent drug use.

Authors:  D A Calsyn; E A Wells; C Fleming; A J Saxon
Journal:  Am J Drug Alcohol Abuse       Date:  2000-05       Impact factor: 3.829

4.  Atypical withdrawal syndrome (organic delusional syndrome) secondary to oxycodone detoxification.

Authors:  D A Fishbain; M Goldberg; R S Rosomoff; H Rosomoff
Journal:  J Clin Psychopharmacol       Date:  1988-12       Impact factor: 3.153

5.  Personality characteristics of drug addicts and alcoholics on the Millon Clinical Multiaxial Inventory.

Authors:  R J Craig; J S Verinis; S Wexler
Journal:  J Pers Assess       Date:  1985-04

6.  Deaths of clients in methadone treatment in Texas: 1994-2002.

Authors:  Jane Carlisle Maxwell; Thomas W Pullum; Karen Tannert
Journal:  Drug Alcohol Depend       Date:  2004-12-07       Impact factor: 4.492

7.  Antipsychotic effect of buprenorphine in schizophrenia.

Authors:  C Schmauss; A Yassouridis; H M Emrich
Journal:  Am J Psychiatry       Date:  1987-10       Impact factor: 18.112

8.  The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients.

Authors:  J S Cacciola; A I Alterman; M J Rutherford; J R McKay; F D Mulvaney
Journal:  Drug Alcohol Depend       Date:  2001-02-01       Impact factor: 4.492

Review 9.  Dopamine and the action of opiates: a reevaluation of the dopamine hypothesis of schizophrenia. With special consideration of the role of endogenous opioids in the pathogenesis of schizophrenia.

Authors:  C Schmauss; H M Emrich
Journal:  Biol Psychiatry       Date:  1985-11       Impact factor: 13.382

10.  [Personality changes in opioid-dependent subjects in a methadone maintenance treatment program].

Authors:  F Trémeau; A Darreye; B Leroy; V Renckly; S Ertlé; H Weibel; F Khidichian; J-P Macher
Journal:  Encephale       Date:  2003 Jul-Aug       Impact factor: 1.291

View more
  1 in total

1.  Character pathology and neuropsychological test performance in remitted opiate dependence.

Authors:  James M Prosser; Daniel Eisenberg; Emily E Davey; Matthew Steinfeld; Lisa J Cohen; Edythe D London; Igor I Galynker
Journal:  Subst Abuse Treat Prev Policy       Date:  2008-11-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.